Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 9, 2010, Pages 616-621

  Wyrzykowska, Paulina ^a   Stalinska, Krystyna ^a   Wawro, Mateusz ^a   Kochan, Jakub ^a   Kasza, Aneta ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Breast cancer; EGF signaling; Elk 1; PAI promoter

Indexed keywords

EPIDERMAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CELL ACTIVATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOCARCINOMA; BINDING SITES; BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; ETS-DOMAIN PROTEIN ELK-1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASES; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 78149409944     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2010.08.004     Document Type: Article

References (19)

1. Bajou K., Maillard C., Jost M., Lijnen R.H., Gils A., Declerck P., Carmeliet P., Foidart J.M., Noel A. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoural angiogenesis and growth. Oncogene 2004, 23:6986-6990.
2. Czekay R.P., Aertgeerts K., Curriden S.A., Loskutoff D.J. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 2003, 160:781-791.
3. Leissner P., Verjat T., Bachelot T., Paye M., Krause A., Puisieux A., Mougin B. Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. BMC Cancer 2006, 31:6-216.
4. Menard S., Fortis M., Castiglioni F., Agresti R., Balsari A. HER2 as a prognostic factor in breast cancer. Oncology 2001, 61:67-72.
5. Faivre E.J., Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 2007, 27:466-480.
6. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell. Biol. 2001, 2:827-837. Review.
7. Kasza A., O'Donnell A., Gascoigne K., Zeef L.A., Hayes A., Sharrocks A.D. The ETS domain transcription factor Elk-1 regulates the expression of its partner protein, SRF. J. Biol. Chem. 2005, 280:1149-1155.
8. Kasza A., Kowanetz M., K., Witek B., Kordula T., Koj A. Epidermal growth factor and proinflammatory cytokines regulate expression of plasminogen activation system in U373-MG astrocytoma cells. Cytokine 2001, 16:187-190.
9. Samarakoon R., Higgins C.E., Higgins S.P., Kutz S.M., Higgins P.J. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp 60(c-src)/MEK-dependent. J. Cell. Physiol. 2005, 204:236-246.
10. Paugh B.S., Paugh S.W., Bryan L., Kapitonov D., Wilczynska K.M., Gopalan S.M., Rokita H., Milstien S., Spiegel S., Kordula T. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 2008, 22:455-465.
11. Vickers E.R., Kasza A., Kurnaz I.A., Seifert A., Zeef L.A., O'Donnell A., Hayes A., Sharrocks A.D. Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death. Mol. Cell. Biol. 2004, 24:10340-10351.
12. Sadowski I., Ma J., Triezenberg S., Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 1988, 335:563-564.
13. Kasza A., Wyrzykowska P., Horwacik I., Tymoszuk P., Mizgalska D., Palmer K., Rokita H., Sharrocks A.D., Jura J. Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of ZC3H12A expression. BMC Mol. Biol. 2010, 6:11-14.
14. LatinkiĆ B.V., Zeremski M., Lau L.F. Elk-1 can recruit SRF to form a ternary complex upon the serum response element. Nucleic Acids Res. 1996, 24:1345-1351.
15. Townsend K.J., Zhou P., Qian L., Bieszczad C.K., Lowrey C.H., Yen A., Craig R.W. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J. Biol. Chem. 1999, 274:1801-1813.
16. Yang S.H., Jaffray E., Hay R.T., Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 2003, 12:63-74.
17. Stevens J.L., Cantin G.T., Wang G., Shevchenko A., Shevchenko A., Berk A.J. Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 2002, 296:755-758.
18. Li Q.J., Yang S.H., Maeda Y., Sladek F.M., Sharrocks A.D., Martins-Green M. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J. 2003, 22:281-291.
19. Buchwalter G., Gross Ch., Wasylyk B. The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression. Mol. Cell. Biol. 2005, 25:10853-10862.